Breast Cancer Survival May Be Associated with Narcotic Pain Relievers

Breast cancer research is an on going study. According to a recent online industry article a new study in the April issue of Anesthesiology reviewed  genetic differences in the way the body reacts to its own morphine-like chemicals and pain-relieving narcotic drugs, and if they have any bearing on breast cancer survival. Preclinical animal studies have theorized that opinoids may encourage tumor growth. “Many are unaware that the human body produces its own morphine-like chemicals every day,” said senior study author Samuel McLean, M.D. “Therefore, if morphine-like chemicals influence cancer survival, then naturally occurring inherited differences in how the body responds to its own morphine-like chemicals and pain-relieving opioid drugs also should be associated with cancer survival.” An excess of more than 2,000 women with breast cancer were participants in the study.

Breast Cancer Study Sheds Light on Tumor Growth

Breast cancer tumor growth is the focus of this study.The authors reviewed six naturally occurring genetic variations that could influence the body’s response to morphine-like chemicals. Specifically, the well-known A118G variation in the mu-opioid receptor gene was analyzed. Genotyping was conducted to assess the link between these variations and breast cancer survival. Further studies are required to analyze how genetic variants influencing opioid system function could relate to cancer survival.  If opioid systems influence tumor growth, then this could encourage new opportunities for effectively treating cancer using virtually non-toxic treatments.”

Breast Cancer Patients Treated by Dr Seify

Breast cancer survival is always on the mind of every breast cancer patient. Dr. Seify becomes involved in the breast cancer diagnosis from the beginning; in hopes of discussing breast reconstruction options in detail with the patient. Dr. Seify approaches the breast reconstruction recommendation portion of the consultation with compassion and empathy. Dr. Seify and the staff realize that each patient is different in their journey following a breast cancer diagnosis. Every breast surgery patient including cosmetic patients who have had procedures such as breast augmentation, breast lift, and breast reduction, are educated concerning their best breast health. They are encouraged to follow the recommendations of their primary care physician concerning mammogram screening. They’re all encouraged to conduct monthly breast self-exams. The most effective means to fighting breast cancer is by preparing women to be knowledgeable and proactive concerning their breast health.

 

NewportPlastic